University of Kansas Cancer Center

Location Info

University of Kansas Cancer Center
Division of Hematologic Malignancies and Cellular Therapeutics
4000 Cambridge St.,
Kansas City, KS 66160
Phone number: (913) 588-9187

Background data

Program type: Adult Program
FACT Approved: Yes
Year CAR T-cell Therapy Program Opened: 2015

CAR T-cell therapies performed

Year 2020 2021 2022 2023
Number Performed 39 57 90 116

Program Director

Name Phone
Mia Strusz, MSHA (913) 588-6030

Medical Director

Name Phone
Joseph McGuirk, DO (913) 588-6030

Physician

Name Phone
Haitham Abdelhakim, MD (913) 588-6030
Sunil Abhyankar, MD (913) 588-6030
Nausheen Ahmed, MD (913) 588-6030
Rajat Bansal, MD (913) 588-6030
Forat Lutfi, MD (913) 588-6030
Joseph McGuirk, DO (913) 588-6030
Leyla Shune, MD (913) 588-6030
Anurag Singh, MD (913) 588-6030
Muhammad Umair Mushtaq, MD (913) 588-6030

Coordinator

Name Phone
Allison Appenfeller, RN, BSN, OCN (913) 588-9821
Sarah Bromert, RN, BSN (913) 588-9821

Social Worker

Name Phone
Cristina Hernandez, LSCSW (913) 908-9583
Jennifer McCabe, LSCSW (913) 218-4936
Jessica Russell, LMSW, CCM (913) 945-9401
Sarah Stevens, LMSW (913) 484-5931

Diseases treated by CAR T-cell therapy

  • Leukemia, acute lymphoblastic
  • Lymphoma
  • Mantle Cell Lymphoma
  • Multiple Myeloma

CAR T-Cell products

  • Abecma (idecabtagene vicleucil, ide-cel)
  • Breyanzi (lisocabtagene maraleucel, liso-cel)
  • Carvykti (ciltacabtagene autoleucel, cita-cel)
  • Kymriah (tisagenlecleucel, tisa-cel)
  • Tecartus (brexucabtagene autoleucel, brexu-cel)
  • Yescarta (axicabtagene ciloleucel, axi-cel)